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 India has highest percentage of diabetic population in the world. 
The complications of diabetes increases with the duration of diabetes and 
the level of glycemic control. Albuminuria is one of the early indicator of 
microangiopathy.Diabetic patients predicts the cardiovascular 
dysfunction when it is associated with micro Albuminuria.  Albuminuria 
judge mainly diabetic kidney disease in people with type II Diabetes 
mellitus, and can also one of a critical judge of all-cause death, mainly 
from cardiac causes. The  reason of the correlation  of albumin uria with 
heart  disease is in doubt, it is mainly due  the coronary vascular and 
structural alteration (raise endothelial permeability, cholesterol 
accumulation , blood clot  production) that causes kidney problems  can  
be associated with  in the heart  structures and, thus, contribute to heart 
failure.  
 Various critical Studies have shown there is link between micro 
Albuminuria and atherothrombotic disease but also other confounding 
factors needs to be ruled out. The presence of a unique feature called 
diabetics cardio myopathy may lead to increase in cardiac disease and 
death in diabetic population.  
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 Major mortality in diabetic patients is due cardiovascular disease 
and its complications. Atherosclerosis and coronary artery disease are the 
most common causes of diabetic cardiac death. Cardiac mortality is 
major contribution from diabetic and hypertensive pt, which will have 
coronary artery disease. 
 Studies also give evidence that distinct cardiomyopathy in patients 
with diabetes mellitus, which is a myocardial disease without the 
presence of coronary artery disease. Hence it is proven that the patients 
with diabetes without coronary atheroma will have increased risk of 
cardiac death than the non diabetic patient therefore the diabetes mellitus 
is considered to be coronary artery equivalent. 
 Early identification of cardiovascular dysfunctions in diabetes pt is 
critical since cardiac disease mainly influences prognosis of diabetic 
population. Hence, it warrants   a clear, easy, and specific imaging index. 
Early echo indices which define the  L.Ventricle  function; like  E F can  
define the  L.Ventricle  function in systole  and mitral valve   velocity 
during diastole  for judging  L.Ventricle  function during diastole. The 
errors in using the conventional parameters are, it can’t be used in 
abnormal ventricle shape (sphere shaped) in dilated cardiac disease and 
abnormal regional wall motion. Mitral valve inflow pattern can’t be used 
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in tachycardia since there is fusion of both E and A waves and pesudonor 
malaistion. 
 The other method which is proposed by Tei and associates has 
proposed the index called TEI INDEX which can assess the global LV 
function both systolic and diastolic functions.  
 TEI INDEX when it is abnormally increased can give prognostic 
value in various cardiac disorders. The advantage of this index is, it is not 
dependent on Heart rate and can simply reproducible.  
 The aim of our study is to assess the diabetic Albuminuria patients 
with cardiac function who is not having any clear evidence of cardiac 
problems using the TEI INDEX and to compare this index with other 





AIMS AND OBJECTIVES 
• To assess the echo car idiographic index  like IVS & posterior wall 
thickness, L.Ventricle functions, E wave flow velocity Decel eration 
time ;mitral inflow velocity ratio between E and A wave;fr actional 
shortening and LV ejection index ;time of LV emptying (ejection 
time) ;time during isovolumic contraction (IV C T); time during 
isovolumic relaxation (IV R T);thickness of IV S; left atrium 
dimension; left ventricle dimension during diastolic;L V MI(left 
ventricle mass and  index); left ven tricle dimension during systolic ); 
thickness of posterior wall.  
 
• To determine the cardiac function in diabetic patient with 
Albuminuria and those patient without Albuminuria without obvious 
previous heart disease using the TEI INDEX and to compare this 






REVIEW OF LITERATURE 
DIABETES: 
 Type II DM is the most common from and India contributes major 
diabetic population in the world. Insulin resistance and inefficient 
production of insulin by beta cells is the main mechanism of DM. Insulin 
secretion decreases with increasing age, and also genetically 
influenced. Hyperglycemia is preceded by insulin resistance and together 
with other factors like lipid disorders, hypertension.  
 Metabolic syndrome is term for the patient with impairment of this 
insulin production. Metabolic syndrome patients will have impaired 
glucose tolerance than overt diabetes and precedes the DM several years 
.The special point here is the diabetic complication starts to set-in before 




DEFINITION AND ESTIMATION OF URINE ALBUMIN 
EXCRETION 
 Micro Albuminuria which is urinary excretion of albumin ranging 
from 30 to 300 mg in a 24-h urine sample. Urinary albumin excretion of 
≥300 mg/24 h can be defined by macro Albuminuria. Uri nary 
Albuminuria usually comprises 20–70% of daily urinary total protein 
excretion. Urine albumin measure ment by dipstick without measuring 
the creatinine excretion will leads to error. Dipstick methods are used to 
estimate the urinary albumin excretion but the precise methods to 
estimate the urinary albumin excretion are  : 
1) Measurement of the albumin-to-creatinine ratio (ACR) in a first 
spot morning sample,  
2) 24 hrs estimation urinary albumin excretion with the measurement 
of creatinine can eliminate the diurnal variation of albumin 
excretion but collection faults can occur.  






  A C R measurement in a first-morning spot urine sample is 
adequate and a 4 hrs urine collection is not necessary as proposed by The 





Micro Albuminuria - Cardiovascular Risk Indicator: 
 
 Micro Albuminuria is strong risk features for cardiovascular 
disease. Dinneen and Gee stein, showed microalbuminuria among 
patients  with type!! Diabetes mellitus is associated with a 3.4-fold risk 
for cardiovascular mortality as compared with normo Albuminuria. 
Identical things   exist in hypertensive people (with out diabetes) and in 
the general population.  
 
Association between urinary albumin excretion and cardiac disease. 
• Diabetic pt with micro Albuminuria has increase risk for cardiac 
morbidity when the albumin excretion increases and initial 
albumin is not essential in predicting the outcome. In the Losartan 
Intervention For End point reduction in hypertension (LIFE) study, 
the reduction of BP is not related in reduction of primary endpoint 
but the reduction of urine albumin excretion can leads to reduction 
of primary end point. Samuelsson et al.  Proposed the in 
hypertensive people have 3 fold increase I cardiac mortality when 




• RENAAL study - In the Reduction of End points in NI DDM with 
the Angiotensin  II  Antagonist Losartan study, renal outcomes is 
related in decrease in micro Albuminuria levels. . The degree of 
Albuminuria increase with aging, presence of co morbid disease 
like diabetes, hypertension. 
• The association of urinary albumin excretion and atherosclerosis 
need to be confirmed because both can coexists with other 
confounding disease. 
 
Cardiac mortality and micro Albuminuria association – assessment. 
Can Micro Albuminuria Cause Cardiovascular Disease? 
 The renal response is evoked by increase renal albumin trafficking 
that can increases the atherosclerosis process. 
Can Athero thrombosis Cause Micro Albuminuria: 
 Micro Albuminuria can reflect the generalized atherosclerosis in 
the body and can leads to increase mortality in atherosclerotic patient 




Association with micro Albuminuria and cardiovascular disease by 
common denominator. 
 
 Many  studies  indicate that micro Albuminuria is ass ociated with 
several  cardio vascular  factors, like  age, male gender, hyper tension, 
DM, smoking, obesity, dy slipidemia and hyper homocysteinemia. 
Metabolic syndrome can also constitutes micro Albuminuria but there is 
in dispute or contra versial in this statement.  
 The complete causes for cardiovascular disease remain unclear, the 
micro Albuminuria can constitute the undiscovered factor which can 
possibly reflects the athero thrombosis but its correlation remains to be 
explained. 
 
Micro Albuminuria and Cardio vascular Disorders; common 
pathogenesis: 
 Micro Albuminuria and cardiovascular Disorders be by a common 
path logic process, proposed hypothesis are:  
 
• Micro Albuminuria cause endothelial malfunction, the endothelial 
malfunction can depends on the function of endothelium like 
homeostasis, fibrin degradation, smooth cell multiplication, WBC 
adhesion, permeability. 
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• NO (nitric oxide is produced by endothelium because it has 
antiprolifertiv, antiplatelet, anti-inflammatory functions. In micro 
Albuminuria and atherosclerosis, this function will be impaired 
and can contribute to the risk of cardiac death in diabetic patients. 
• The evidence of low grade, chronic inflammation markers like C- 
reactive protein, TNF B, interlukins are elevated as a product of 
endothelial dysfunction and further increase the risk of 
atherothrombotic in diabetic patients. 
 
CARDIOVASCULAR DISEASE: 
 Coronary atherosclerosis is major causes of major pathogenesis in 
diabetic population. Diabetic patients, the main cause of LV failure 
(90%) is due CAD and hypertension. But specific patients have cardiac 
dysfunction in the absence of CAD, which is proven in autopsy which is 
termed as diabetic cardiomyopathy. Hence in diabetic pt, independent of 
CAD, there further increase risk of heart failure. 
 
The pathology of diabetic cardio myopathy: 
Damage in ventricular myocardium: 
 In diabetic pt the CAD are not essentially different from the 
general population, but the CAD have, extensive atheroma, diffuse lesion 
and small distal vessel disease and treatment strategy will vary for 
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diabetic CAD patients. Myocardial variation  in diabetic patient are due 
AGE (advance d end stage glycation)which can hinder the ventricular 
compliance ,contractility, and LV hypertrophy can occur due to 
interstitial and perivascular fibrosis as the diabetic progression occurs. 
 
 LV diastolic functions is impaired due to impaired relaxation and 
increased atrial filling. Previous studies which have used conventional 
echo method found to 30% Lv diastolic function. Using newer Doppler 
parameters, LV DD in diabetic patients will be around 60% when 

























 Diabetic patient having high incidence of LV diastolic dysfunction 
is due to cardiac myocardial fibrosis and amount of fibrosis is directly 
related to HBA1C level in serum.  The myocardial fibrosis is due to AGE 
in myocardium which can be decreased by lyses of collagen cross links 
.furthermore the endothelial dysfunction is aggravated by hyperglycemia 
by increase in myocardial free radical contents, decrease EDRF. It is also 
associated with lipotoxixcity which is direct toxic to myocardium can 
















(Metabolic Abnormalities in Hyperglycemia) 






Free Fatty Acid Liberation and Endothelial Function 
 
 Endothelial function through several mechanisms may be impaired 
by Free fatty acids, free radicals, dyslipdemias, small dense LDL which 
is more atherogenic.Other dyslipdemias like hypertriglyceredemia, high 
HDL also associated with malfunction of endo thelium. 
 
Insulin Resistance and NO 
 
 Nitric oxide productions are stimulated by insulin which leads to 
endothelial derived vasodilation.But in insulin resistance develops; the 
NO related vasodilatations were reduced. Hence insulin sensitizing drugs 
like metformin, glitazone can leads to NO related vasodilatations. 
 
Diabetes mellitus and Smooth Muscle Function 
 
 The diabetic patient have increased tendency for migration and 
proliferation  of smooth cell in the atherosclerotic plaque which leads to 
progression of coronary disease and lesion become hard which gives 
difficulty during the coronary percutaneous interventions. 
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Diabetes, Thrombosis, & Coagulation 
 
 Platelet function is impaired in diabetic pt because of this 
expression GpII b,IIIa is elevated which in turn augments the vWF and 
platelet fibrin interaction and more rapid formation of thrombus and 









 Left ventricular measurement can be calculated by Penn 
conventional method taking leading edge with trailing edge.. It includes 
Left V diameter in end diastole and end of systole. Left V volumes were 
measured according to the popular Teichholz M-mode for rmula volume 
=7 D 3/ (2 .4 + D. Ejection fraction was measured (LV EDvolume−LV 
ES volume)/LV ED volume. 
 L left V mass can be measured   by M-m ode formula of Troy et al 
by American Society of Echocardiography (ASE) guidelines. LV mass / 
body surface area gives the LV mass index. 
 Left V wall mot ion score measured as the average score in a 17-
segment model of the left ventricle using 2D echo images.  
Calculation of the Tei index 
 The Tei index is a number and is calculated from the ratio of time 
intervals (a-b/b) derived with the help of pulsed Dop pler 
echocardiography. Locating the sample volume at the tips of the mitral 
valve leaflets, in the apical 4-chamber view, enables the measurement of 
a, which is the time interval between the end and the start of Trans mitral 
flow. The sample volume is then located in the LV outflow tract, just 
below the aortic valve (apical 5-chamber viewA5C) 
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 For the measurement of b, the LV ejection time. The interval a  
includes the isovolumic contraction time (IVCT), the ejection time (ET) 
and the isovolumic relaxation time (IVRT), and the Tei index may also 
be expressed by the formula IVCT+IVRT/ET. 
 For the evaluation of the right ventricular (RV) Tei index the a 
interval, from the end to the start of trans-tricuspid flow (the interval 
from the end of the A wave to the start of the E wave), is obtained from 
the apical 4-chamber view with the Doppler sample volume located 
between the tips of the tricuspid valve leaflets. The b interval (RVET) is 
measured from the parasternal long-axis view, with the sample volume 
























Pulse Wave Doppler and Tissue Doppler Demonstrating the  
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Measurement of Tie Index 
TEI INDEX & and alteration factor, preload 
 In order to determine the Tei index determinant like preload of 
heart, which can likely to change the value, study population of previous 
myocardial infarction were taken. In the patients  
 Preload of heart is reduced by: Vals alva man oeuvre, and 
administration of sublingual nitroglycerine.  
 Preload of heart is increased by: passive leg raising).                        
In the control population group the index shows significantly raise   
during the Vals alva man oeuvre (due to a reduction in Ejection Time), 
elevating the limb passively (due to mainly raise in Iv CT) and after 
giving nitro-glycerin (as due to decline in Ejection time and elongation in 
of IV C T).on the contrary, the previous myocardial infarction patient 
doesn’t show any change in Tei index. .in the population having the  pre 
load  which is reduced the IV CT/E T ratio clearly found that  it is 
reduced  while the ratio between IV RT/E T found to be raised , leaving 
the index remain  unchanged. This study has clearly demonstrated that 
the change in preload ha only mild alteration in the Tei index and it is 
considered to preload independent parameters.  
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TEI INDEX & hemodynamic measur4ments. 
 Idiopathic cardiac dysfunction and ischemic Lv dysfunction were 
subjected cardiac cath study and Doppler examination. 
 The measurements like +dP/dT (rate of raise of pressure during 
systole), -dP/dT (rate of pressure drop), t a u time constant were 
measured. The Tei index is comparable with the study variables hence it 
can be concluded that the Tei index is a more sensitive indices for 
diastolic function than any conventional parameters.  
Tei index in cardiac dysfunction 
 
 In cardiomyopathy, the tie index reflects the severity of myocardial 
malfunctions and it is clearly evidenced that it gives the independent 
outcome of the cardiomyopathy patient. Higher the value, worse the 
prognosis. It is similar the ejection fraction. The tie index has positive 
correlation with NYHA class, l.v entricualr dimensions, one year, and 
five year survival outcome.  
Tei index measurement 
 The index is derived from pulse Doppler can help to assess the 
global l. ventricular function is the Tei Index which is coined by Tei and 
his colleagues. 
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 The average normal value of the Tei in-dex is 0.39 ±  while for the 
right ventricle (RV) it is 0.28 ± 0.04. 
 In adults’ population, values of the L.Ventricle index less than 0.40 
and for the R.Ventricle less than 0.30 are considered normal. 
 The Tei index value will be increased depending upon the 























































 102 random diabetic populations who are attending cardiology 
Department, madras medical college for cardiac assessment are taken for 
study and included as study population .Those diabetic population with 
clinically normal heart like normal LV systolic function, without any 
chest pain, previous heart attack, cardiac failure. And also they should 
not have imaging signs of myocardial infarction in ECG and ECHO. 
There are no age limit and for the patient in our study.  
 Relevant history, clinical examination, biochemistry parameters, 
E.C.G, echocardiography was taken for all the patients.     
 Echocardiography examinations were performed Philips HD7XE 
Echocardiography machine) with a 2.5-Megta Hz probe. the 
echoaridiographic index  like IVS & posterior wall thickness, L.Ventricle  
functions, E wave flow velocity Decel eration time ;mitral inflow 
velocity ratio between E and A wave; fractional shortening and LV 
ejection index ;time of LV emptying (ejection time) ;time during 
isovolumic contraction (IV CT); time during isovolumic relaxation (IV 
RT);thickness of IVS; left atrium dimension; left ventricle dimension 
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during  dia stolic;LV MI(left ventricle mass  and  index); left ventricle 
dimension during systolic ); thickness of posterior wall were measured 
for the study population with angina symptoms both clinically and 
imaging wise. 
INCLUSION CRITERIA:   
 
        All patients with Diabetics, ,with L.Ventricle EF > 55%,no previous 
H/O MI, angina, heart failure attending cardiology OPD in Rajiv Gandhi 
Government General Hospital, Chennai. 
 
EXCLUSION CRITERIA 
We excluded patients with  
¾ rheumatic heart disease  
¾ arrhythmias which can confound in mitral inflow like 
fibrillation,av block 
¾ heart disease from birth;  
¾ hyper thyroidism; hypo-thyroidism; and  




The study population of 102 patients was dived into three groups; 
* NO albuminuria -  40  patients (22 male and 18 female, average  
age 51) 
* MICRO albuminuria - 40 patients (25 male & 10 female with 
average, age 49yrs) 
* MACRO  albuminuria - 22 patients (12 male & 15 female with 
average age 51yrs) 
Echocardiography 
 
 The study population were examined using echo machine  (Phillips  
with a a probe frequency of 2.5 Mega Hz .) the echocardiography index  
like IVS & posterior wall thickness, L.Ventricle  functions, E wave flow 
velocity Decel eration time ;mitral inflow velocity ratio between E and A 
wave; fractional shortening and LV ejection index ;time of LV emptying 
(ejection time) ;time during isovolumic contraction (IV CT); time during 
isovolumic relaxation (IV RT);thickness of IVS; left atrium dimension; 
left ventricle dimension during diastolic;LV MI(left ventricle mass and  
index); left ventricle dimension during systolic ); thickness of posterior 
wall. 
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 Biochemical Parameters: Measurement of albumin-to -creatinine 
ratio   in a random or first MOR ning spot collection. 
 Micro Albuminuria can be proposed as daily excretions of 30 to 
300 mg/day of albumin in urine and macro  
 Albuminuria be proposed as daily excretions of rate 3 00 mg/day. 
Analysis:  
 The final value are mentioned as mean standard deviation. The 
values were studied with Kol mogorov-S mirnov method. Correlation of 
various groups (as noalbuminuria, micro Albuminuria, macro bu-
minuria) done by Krus kal-Wal lis method. The test was used to 
determine the differences of the cat egoric variables between the groups. 
Pear son and Spear man correlation co-efficient were used for 
calculation. The cor relation of urine albumin and various echo indices 
were studied using regression stepwise multiple analysis. The p value 
which are less than 0.4 are considered to significant. 
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DATA ANALYSIS FROM THE OBSERVED 
VALUE 
  102 patients of established diabetes patient were selected for the 
study. Among them 60 were males and 42 were females. Female have 
significant higher percentage of no Albuminuria and micro Albuminuria 
than with macro albuminuria.60% of all patients have systemic 
hypertension. The degree of urine albumin is increased as the duration 
diabetic years increases from NO albuminuria to micro & 
macroalbuminuria.  Serum creatinine was increased with the patients 
having macroalbuminuria than patients with micoalbuminuria and no 
albuminuria. The values are  
• Noalbumiuric patients: 12േ6  8.0 mg/d 
• Micro albuminric patients: 85  േ50 mg/d 
• Macro Albuminuria patients:  889  േ564 mg/d  
Age of the patients ranged from 29 years to 70 years with the mean 
value of age is 48.5 years. Among female patients age range from 34 
years to 68 years with the mean age of 46.5 years. For the male patients it 
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Among the male patients Albuminuria is more common in the age 
group between 40-60 years of age. Albuminuria is less common before 
40years of age in both males and females. In female gender high 
prevalence was noted between 50-60 years of age. In the age group of 60-
70 years Albuminuria is slightly higher in the females when compared to 
males.  
Among these 102 patients 40 patients had no Albuminuria, 40 
patients had micro Albuminuria and 22 patients macro Albuminuria. 
These comprises of 39% of patients with no Albuminuria, 39% of 
patients with micro Albuminuria and 21% of patients with macro 
Albuminuria 
Table 2: Severity of Albuminuria 
ALBUMINURIA 
Male Female Total 









NO 24 40 16 38 40 39.5 
MICRO 24 40 16 38 40 39.5 
MACRO 12 20 10 24 22 21 





ALBUMINURIA BETWEEN MALES AND FEMALES
 
 
The prevalence of Albuminuria is more common in males. The 



















The levels of Albuminuria increase with the patients who is taking 
insulin which is positively correlated (p<0.005). This can be due to long 
standing diabetes and diabetic complications for which the patients were 



















Picture represents normal LV contraction with normal ejection 








In our study population thicknesses of left ventricular PW in macro 
Albuminuria population (P<0.01) were clearly increased than micro and 
noalbuminuric patients. Left ventricular mass index is proportionately 





















Echo picture represents, calculation of various parameters for 







The average TEI INDEX values were significantly larger than the 
general population. The TEI value were proportionately elevated from no 






















It’s clearly evident from this study population that the usual echo 
parameters were  normal and TEI value were begin to increase which 
shows that the TRI index predict the cardiac outcomes before it can be 
detected by conventional echo parameters. 
Study proposed that diabetic population will have diastolic 
malfunction before the systolic function is altered .our study population 
also shown similar findings and proven this which, clearly demonstrated 
by Liu al study. 
 The E wave deceleration time didn’t show any significant 
difference between the 3 study groups (micro Albuminuria 211 ט84 milli 
seconds, macro Albuminuria 209  ט 76 milli seconds) ; 


















There is stepwise increase in IVRT in 3 groups of study population 
(P<0.004). Watsc hinger et al study contradicts our findings which means 



















The cardiac function like Ef, RWMA were normal in our study 
group. 
TEI INDEX which reflects the global LV function both systolic 
and diastolic function were increased guardedly from the increasing 

























IVCT is influenced by preejection period and it is increased in our 
study population in graded manner and hence t is suggested that IV CT 
predicts impaired myocardial performance. 
Patients with DM, coronary artery issues, micro- angiopathy, inter-
stitial fibrosis, extra cellular collagen infiltration, calcium transport 
alterations, and neuro-hormonal modifications, can hinder cardiac 
function. 
 















Our study also gives evidence for increasing TEI index in diabetic 
complication patients. 
 
In this current study, the TEI is increase in a graded fashion from 
the study group (p<0.03).  
The sub study analysis of our study groups shows tie index is 






















This graph represent the positive correlation of diabetic 
complications and duration of diabetes (p<0.02).  
By above all the observation, it was shown that TEI INDEX 
predicts the cardiac dysfunction before it can be detected by conventional 



















Our study was carried out to provide the views on Doppler-derived 
myocardial performance index which is classically proposed as TEI index 
in general diabetic patient diabetes mellitus with no Albuminuria as 
correlated with micro Albuminuria and macro Albuminuria. Our current 
studies, average value of TEIINDEX were found to be elevated than in 
the non diabetic population. The average TEI INDEX values were 
significantly larger than the general population. The TEI value were 
proportionally elevated from no albuminurc pt to micro and macro 
Albuminuria patients (p<0.001) 
The study groups have clearly shown that the normal lV 
Function parameters like ejection fraction, RWMA were normal 
and TEI INDEX has shown increased in value and it helps to predict the 
diabetic cardiovascular dysfunction earlier. 
Diabetic population was LV myocardial relaxing abnormality 
before LV systolic dys function occurs.  
The mitral valve inflow velocity ratio was significantly decreasing 
from the 3 study groups which are shown in different studies. 
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The study population didn’t show any difference in mitral E 
velocity deceleration time in 3 groups. 
The study clearly shown that there is graded increase in IV RT in 
diabetic patient s with increasing severity of Albuminuria mainly because 
increase in pre ejection periods. 
The Tei index were also shown graded increase in diabetic patients 
with more number of diabetic years, increasing HBA1C,diabetic 
complications, and patient taking insulin( reflecting the complications) . 
 TEI INDEX also increase graded in our study population with 






There is clear-cut positive correlation between the LEFT 
VENTRICULAR TEI INDEX and the degree Albuminuria in diabetics. 
LV TEI INDEX can be a useful marker in early detection of 
cardiac dysfunction in diabetic patients and helps to prognosticate the 
diabetic population. 
LV Tei index is an early parameter to observe the ventricular 
dysfunction before it can be detected by conventional echocardiography 
parameters. 
This index increases in stepwise pattern in diabetic population 





The evidence of coronary artery disease cannot be ruled out 
confidentially because, in this study we used only history, ECG and 
ECHO for ruling out the CAD and gold standard like coronary 
angiogram, treadmill test was not done. 
The other confounding factors 
Like the treatment drugs which the study population are taking can 
confound the ventricular function cannot be excluded.  
BIBILIOGRAPHY 
 
1. Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non-
insulin-dependent diabetes. Diabet Med 1988;5:126-34. 
2. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald 
AP,Jackson G. Prospective study of microalbuminuria as predictor 
of mortality in NIDDM. Diabetes 1992;42:736-41. 
3. Gall MA, Rossing P, Skott P, Damsbo P, Vaag A, Bech K, et al. 
Prevalance of micro- and macroalbuminuria, arterial 
hypertension,retinopathy and large vessel disease in European type 
2 (non-insulin-dependent) diabetic patients. Diabetologia 
1991;34:655. 
4. Mattock MB, Keen H, Viberti GC, el-Gohari MR, Murrells TJ, 
Scott GS, et al. Coronary heart disease and urinary albumin 
excretion rate type 2 (non-insulin-dependent) diabetic patients. 
Diabetologia 1988;31:82-7. 
5. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Doppler-
derived myocardial performance index: correlation with 
simultaneous measurements of cardiac catheterization 
measurements. J Am Soc Echocardiogr 1997;10:169-78. 
6. Eidem BW, Tei C, O’Leary PW, Cetta F, Seward JB. 
Nongeometric quantitative assesment of right and left ventricular 
function:  yocardial performance index in normal children and 
patients with Ebstein nomaly. J Am Soc Echocardiogr1998;11:849-
56. 
7. Yeo TC, Dujardin KS, Tei C, Mahoney DW, McGoon MD,Seward 
JB. Value of Doppler-derived index combining systolicand 
diastolic time intervals in predicting outcome in primary 
pulmonary hypertension. Am J Cardiol 1998;81:1157-61. 
8. Tei C, Dujardin KS, Hodge DO, Bailey KR, McGoon MD,Tajik 
AJ, et al. Doppler echocardiographic index for assessment of 
global right ventricular function. J Am Soc Echocardiogr 
1996;9:838-47. 
9. Dujardin KS, Tei C, Yeo TC, Hodge DO, Rossi A, Seward 
JB.Prognostic value of a Doppler index combining systolic and 
diastolic performance in idiopathic-dilated cardiomyopathy.Am J 
Cardiol 1998;82:1071-6. 
10. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, et 
al. New index of combined systolic and diastolic myocardial 
performance:  
11. Gerstein H, Mann J, Yi Q, et al.. Albuminuria and risk of 
cardiovascular events, death, and heart failure in diabetic and 
nondiabetic individuals. JAMA. 2001;286(4):421 426. 
12. Gerstein HC, Mann JFE, Pogue J, et al.. Prevalence and 
determinants of microalbuminuria in high-risk diabeticand 
nondiabetic patients in the Heart Outcomes Prevention Evaluation 
Study. Diabetes Care. 2000;23(2):B35 -B39. 
13. Tapp RJ, Shaw JE, Zimmet PZ, et al.. Albuminuria is evident in the 
early stages of diabetes onset: resultsfrom the Australian Diabetes, 
Obesity, and Lifestyle study. Am J Kidney Dis. 2004;44(5):792 
798. 
14. Donnelly R, Yeung JMC, Manning G. Microalbuminuria: a 
common, independent cardiovascular risk factor,especially but not 
exclusively in type 2 diabetes. J Hypertens. 2003;21(1):S7 S12. 
15. Standards of medical care in diabetes: nephropathy screening and 
treatmenta.Available  Kuroda T, Seward J, Rumberger J, Yanagi H, 
Tajik A. LV 
16. Bryg R, Williams G, Labovitz A. Effect of aging on left ventricular 
diastolic filling in normal subjects. Am J Cardiol. 1987; 59: 971-
974. 
17. Berk M, Xie G, Kwan O, et al. Reduction of left ventricular 
preload by lower body negative pressures alters Doppler 
transmitral filling patterns. J Am Coll Cardiol. 1990; 16: 1387-
1392. 
18. Tei C, Ling L, Hodge D, et al. New index of combined systolic and 
diastolic myocardial performance: a simple and reproducible 
measure of cardiac function—a study in normals and dilated 
cardiomyopathy. J Cardiol. 1995; 26: 357-366. 
19. Tei C. New non-invasive index of combined systolic and diastolic 
ventricular function. J Cardiol. 1995; 26: 135-136. 
20. Tei C, Dujardin K, Hodge D, Kyle R, Tajik A, Seward J. Doppler 
index combining systolic and diastolic myocardial performance: 
clinical value in cardiac amyloidosis. J Am Coll Cardiol. 1996; 28: 
658-664. 
21. Tei C, Dujardin K, Hodge D, et al. Doppler echocardiographic 
index for assessment of global right ventricular function. J Am Soc 
Echocardiogr. 1996; 9: 838-847. 
22. J. Effect of reperfusion on biventricular function and survival after 
right ventricular infarction. N Engl J Med. 1998; 338: 933-940. 
23. Møller J, Dahlström U, Gøtzsche O, et al. Effects of losartan and 
captopril on left ventricular systolic and diastolic function after 
acute myocardial infarction: Results of the Optimal Trial in 
Myocardial Infarction with Angiotensin II Antagonist Losartan 
(OPTIMAAL) echocardiographic substudy. Am Heart J. 2004; 
147: 494-501. 
24. Poulsen S, Jensen S, Tei C, Seward J, Egstrup K. Value of the 
Doppler index of myocardial performance in the early phase of 
acute myocardial infarction. J Am Soc Echocardiogr. 2000; 
25. Nearchou N, Tsakiris A, Tsitsirikos M, et al. Tei index as a method 
of evaluating left ventricular diastolic dysfunction in acute 
myocardial infarction. Hellenic J Cardiol. 2005; 46:35- 42. 57. 
26. Jugdutt B. Prevention of ventricular remodeling post myocardial 
infarction: timing and duration of therapy. Can J Cardiol. 1993; 9: 
103-114. 
27. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular 
dysfunction and remodeling after myocardial infarction. Potential 
mechanisms and early predictors. Circulation. 1993; 87: 755-763. 
28. Appleton C, Hatle L, Popp R. Relation of transmitral flow velocity 
patterns to left ventricular diastolic function: new insights from a 
combined hemodynamic and Doppler echocardiographic study. J 
Am Coll Cardiol. 1988; 12: 426-440 activator. Am J Physiol Heart 
Circ Physiol. 2002;283:H949–H957. 
31. Aasum E, Hafstad AD, Severson DL, Larsen TS. Age-
dependentchanges in metabolism, contractile function, and 
ischemic sensitivity in hearts from db/db mice. Diabetes. 
2003;52:434–441. 
32. Barouch LA, Berkowitz DE, Harrison RW, O’Donnell CP, Hare 
JM.Disruption of leptin signaling contributes to cardiac 
hypertrophy independently of body weight in mice. Circulation. 
2003;108:754 –759. 
33. Boudina S, Sena S, O’Neill BT, Tathireddy P, Young ME, Abel 
ED. Reduced mitochondrial oxidative capacity and increased 
mitochondrial uncoupling impair myocardial energetics in obesity. 
Circulation. 2005; 112:2686 –2695. 
34. Broderick TL, Poirier P. Cardiac function and ischaemic tolerance 
during acute loss of metabolic control in the diabetic BB Wor rat. 
Acta Diabetol. 2005;42:171–178. 
35. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, 
Yun UJ, Cooksey RC, Litwin SE, Abel ED. Reduced cardiac 
efficiency and altered substrate metabolism precedes the onset of 
hyperglycemia and contractile dysfunction in two mouse models of 








Address:   
 
CD No. : 
Assesement of  doppler derived myocardial performance 
index in diabetic patients with albuminuria 
No albuminuria            Microalbuminuria          Macroalbuminuria 
AGE    
SEX    
BMIA    
HYPERTENSION    
SMOKING    
DURATION OF DM    
TYPE OF DM    
TOTAL CHOLESTROL    
TRIGLYCERIDES    
HDL    
LDL    
SERUM CR    
ANTI DIABETIC DRUGS 
INSULIN: 
OHA 
    
ANTI HYPERTENSIVE    
ACEI    
ATII BLOCKER    




ECG                                               : ISCHAEMIC CHANGES    േ 
 













ECHOCARDIOGRAPHIC ASSESSMENT  
 




LV:                 EDD-                     ESD-                     EF-                   
FS- 
THICKNESS: IVS,PW   
Mitral valve: 
Aortic valve:     LVOT diameter: 
LA: 
Tricuspid valve: 
Pulmonary valve:   
2 D and DOPPLER HEMODYNAMIC ASSESSMENT: 
Mitral inflow: 
E-wave:        Peak velocity-     DT- 





Mitral annular:             E’ velocity-                                   A’ velocity- 
    E/E’ ratio:   MASV  
    TASV 
E  PROPOGATION VELOCITY 
IVRT: 
IVCT: 
Tei INDEX :IVCT+IVRT/ET 
Tricuspid inflow: 
 
E-wave:        Peak velocity-      DT- 
















                  
PATIENT CONSENT FORM 
Study Details :Assessment of   Left Ventricular doppler derived 
myocardial performance index in diabetic patients with albuminuria 
Patient may check (9) these boxes. 
PARTICIPANT NAME:                                          DATE:                            
 AGE:              SEX:                                    I.P.NO. : 
The details of the study have been provided to me in writing and explained to 
me in my own language. 
I confirm that I have understood the purpose of the above study. I 
have the opportunity to ask the question and all my questions and 
doubts have been answered to my complete satisfaction. 
I understand that my participation in the study is voluntary and 
that I am free to withdraw at any time without giving any reason, 
without my legal rights being affected. 
I understand that investigator, the institution, regulatory 
authorities and the ethical committee will not need my permission 
to look at my health records both in respect to the current study 
and any further research that may be conducted in relation to it, 
even if I withdraw from the study. I understand that my identity 
will not be revealed in any information released to third parties or 
published, unless as required under the law. I agree not to restrict 
the use of any data or results that arise from this study.  
 I hereby consent to undergo complete physical examination, and 
diagnostic tests including hematological, biochemical, 
radiological and urine examinations 
I have been given an information sheet giving details of the study. 
I hereby consent to participate in the above study  
                                                                                                                                         
          
Signature of the Participant 
INFORMATION SHEET 
 
• We are conducting a study of the "Assesement of  doppler derived 
myocardial performance index in diabetic patients with 
albuminuria ’’at theDepartment of Cardiology ,Rajiv Gandhi Govt. 
General Hospital, Chennai.  
• The purpose of this study is to analyse the association of Doppler 
derived myocardial performance index in diabetic patients  with 
albuminuria.  
• The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or presentation 
resulting from the research, no personally identifiable information will 
be shared. 
 
• Taking part in this study is voluntary. You are free to decide whether 
to participate in this study or to withdraw at any time. Your decision 
will not result in any loss of benefits to which you are otherwise 
entitled. 
 
•  The results of the study may be intimated to you at the end of the 
study period or during the study if anything is found abnormal which 
may aid in the management or treatment. 
 
 

























































































































































































































































































1  Aanbalagan  65  1  53  152  22.94 
250
120  24  79  17 
Y 8.0 8.5 0.8 OHA Y  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
2  Bashir  44  1  57  150  25.33 
600
142  30  100  12 
Y 9 9.1 0.9 insulin Y  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
3  Elumalai  49  1  62  172  20.96 
25
165  34  104  27 
N 9.5 9.4 1.4 OHA N  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
4  Aruldoss  59  1  66  171  22.57 
37
165  33  111  21 
N 9.0 7.9 2.8 Insulin Y  1.9 2.2 3.0 4.9 69 1.2 222 114 56 0.9 198
5  Bakthavatchalam  37  1  67  169  23.46 
368
224  49  121  54 
N 11 8.9 1.0 OHA  N  0.6 0.7 2.4 4.5 67 0.9 209 100 41 0.4 160
6  Subramani  57  1  53  158  21.23 
900
224  50  145  29 
N 7.o 10 0.6 OHA N  1.1 1.1 3.2 4.2 58 0.8 211 90 39 0.44 187
7  Srinivasan  57  1  66  170  22.84 
400
142  28  94  20 
N 7.1 7.0 1.1 OHa N  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189
8  Indira  51  2  50  166  18.14 
23
357  46  124  28 
N 8.0 6.3 0.8 OHA Y  0.9 1.0 3.3 4.7 67 1.6 212 102 40 0.44 150
9  Gunasekar  45  1  50  145  23.78 
21
327  65  234  28 
Y 9.0 8.5 0.8 OHA Y  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
10  ganesh  53  1  55  169  19.26 
400
181  36  132  13 
N 11 9.1 0.9 insulin N  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
11  faizer ali  48  1  54  162  20.58 
23
216  44  130  42 
N 7.o 9.4 1.4 OHA Y  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
12  ellappan  48  1  85  170  29.41 
21
219  44  143  32 
N 8.0 7.9 2.8 Insulin Y  1.9 2.2 3.0 4.9 69 1.2 222 114 56 0.9 198
13  Ekambaram  41  1  89  182  26.87 
30
203  30  95  78 
N 9 8.9 1.0 OHA  Y  0.6 0.7 2.4 4.5 67 0.9 209 100 41 0.4 160
14  Dhanasekar  53  1  70  176  22.60 
1
242  49  142  51 
N 9.5 10 0.6 OHA Y  1.1 1.1 3.2 4.2 58 0.8 211 90 39 0.44 187
15  Baskaran  23  1  66  164  24.54 
849
188  39  116  33 
Y 7.1 7.0 1.1 OHa N  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189
16  Arumugam  28  1  54  153  23.07 
157
172  36  117  19 
Y 8.0 6.3 0.8 OHA N  0.9 1.0 3.3 4.7 67 1.6 212 102 40 0.55 150
17  arthikani  36  2  55  151  24.12 
190
247  50  157  40 
N 9.0 8.5 0.8 OHA N  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
18  Antony  59  1  63  174  20.81 
456
278  57  190  31 
N 11 9.1 0.9 insulin Y  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
19  Alli  44  2  78  172  26.37 
243
358  46  135  35 
N 7.o 9.4 1.4 OHA y  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
20  Ahmed basha  40  1  65  167  23.31 
221
253  51  150  52 
Y 5.6 7.9 2.8 Insulin Y  1.9 2.2 3.0 4.9 69 1.2 222 114 56 0.9 198
21  Ahmad Ullakhan  58  1  62  165  22.77 
21
210  38  148  24 
N 8.0 8.9 1.0 OHA  Y  0.6 0.7 2.4 4.5 67 0.9 209 100 41 0.4 160
22  Abdhul Razak  45  1  54  162  20.58 
23
157  34  84  39 
N
N 
6.3 10 0.6 OHA N  1.1 1.1 3.2 4.2 58 0.8 211 90 39 0.44 187
23  abdul  49  1  57  160  22.27 
234
159  32  73  54 
Y 9.0 7.0 1.1 OHa Y  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189
24  Arumugam  44  1  75  176  24.21 
235
205  41  126  38 
N 11 6.3 0.8 OHA N  0.9 1.0 3.3 4.7 67 1.6 212 102 40 0.41 150
25  Periyasamy  45  1  41  159  16.22 
250
184  37  131  16 
N 7.o 8.5 0.8 OHA N  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
26  Pasupathi  60  1  80  160  31.25 
600
317  63  207  47 
N 5.5 9.1 0.9 insulin N  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
27  Panner Selvam  58  1  56  170  19.38 
25
245  49  133  63 
N 8.0 9.4 1.4 OHA Y  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
29  Pahurdeen  65  1  39  160  15.23 
37
178  38  114  26 
Y 9 7.9 2.8 Insulin Y  1.9 2.2 3.0 4.9 69 1.2 222 114 56 0.9 198
30  Nagaraj  60  1  66  180  20.37 
368
202  40  125  37 
N 9.5 8.9 1.0 OHA  N  0.6 0.7 2.4 4.5 67 0.9 209 100 41 0.4 160
31  Murugan  44  1  57  150  25.33 
900
142  30  100  12 
Y 9.0 10 0.6 OHA Y  1.1 1.1 3.2 4.2 58 0.8 211 90 39 0.44 187
32  Murali  60  1  68  170  23.53 
400
310  62  209  39 
N 11 7.0 1.1 OHa Y  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189
33  Vijayan  52  1  51  174  16.85 
23
292  58  217  17 
Y 7.o 6.3 0.8 OHA Y  0.9 1.0 3.3 4.7 67 1.6 212 102 40 0.6 150
34  Vijayakumari  52  2  55  180  16.98 
21
258  45  135  22 
N 5.2 8.5 0.8 OHA Y  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
35  Vijay  60  1  71  153  30.33 
400
193  39  115  39 
N 8.0 9.1 0.9 insulin N  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
36  Veeramuthu  50  1  66  176  21.31 
23
238  49  157  23 
Y 9 9.4 1.4 OHA N  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
37  Thulasidoss  67  1  56  169  19.61 
21
234  45  171  18 
N 9.5 7.9 1.9 OHA N  1.1 1.1 3.2 4.2 58 0.8 211 90 39 0.44 187
38  Thangamani  55  1  49  153  20.93 
30
155  31  98  26 
Y 6.7 7.9 2.8 Insulin Y  1.9 2.2 3.0 4.9 69 1.2 222 114 56 0.9 198
39  Ravichndran  54  1  62  165  22.77 
1
210  38  148  24 
N 9.0 8.9 1.0 OHA  Y  0.6 0.7 2.4 4.5 67 0.9 209 100 41 0.4 160
40  Tajum Begam  40  2  70  170  24.20 
849
264  53  182  29 
N 11 10 0.6 OHA N  1.1 1.1 3.2 4.2 58 0.8 211 90 39 0.44 187
41  Rathakrishnan  45  1  76  159  30.06 
157
222  44  144  34 
N 7.o 7.0 1.1 OHa Y  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189
42  Anif  50  1  56  160  21.88 
190
135  28  129  22 
N 9.0 6.3 0.8 OHA N  0.9 1.0 3.3 4.7 67 1.6 212 102 40 150
43  allathiya  48  2  61  176  19.69 
456
276  55  141  80 
N 11 6.4 0.9 OHA N  1.1 1.1 3.2 4.2 58 0.8 211 90 39 0.44 187
44  Kesavan  42  1  59  170  20.42 
243
138  20  86  32 
N 7.o 8.5 0.8 OHA N  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
45  Selvaraj  50  1  51  157  20.69 
221
156  32  82  42 
Y 8.0 9.1 0.9 insulin Y  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
46  Xavier  58  1  73  173  24.39 
21
140  28  92  20 
N 9 9.4 1.4 OHA Y  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
47  Stephen  40  1  70  160  27.34 
23
217  44  130  43 
N 9.5 7.9 2.8 Insulin N  1.9 2.2 3.0 4.9 69 1.2 222 114 56 0.9 198
48  Shanthi  60  2  50  143  24.45 
234
240  50  162  28 
N 9.0 8.9 1.0 OHA  Y  0.6 0.7 2.4 4.5 67 0.9 209 100 41 0.4 160
49  Shanmugam  45  1  63  167  22.59 
235
190  49  104  37 
N 11 10 0.6 OHA Y  1.1 1.1 3.2 4.2 58 0.8 211 90 39 0.44 187
50  Shankar  63  1  57  158  22.83 
250
147  30  98  19 
Y 7.o 8.5 0.8 OHA Y  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
51  S.Rajan  66  1  55  166  19.96 
600
212  43  151  18 
N 7.1 9.1 0.9 insulin Y  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
52  Ravi  61  1  60  168  21.26 
25
136  41  71  24 
Y 8.0 9.4 1.4 OHA N  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
53  Ramu  39  1  86  186  24.86 
37
196  40  125  31 
Y 9.0 7.0 1.1 OHa N  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189
54  Santhanam  66  1  54  150  24.00 
368
321  45  168  45 
N 11 6.3 0.8 OHA N  0.9 1.0 3.3 4.7 67 1.6 212 102 40 0.6 150
55  Ravindran  48  1  72  171  24.62 
900
167  34  95  38 
Y 7.o 8.5 0.8 OHA Y  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
56  Mary  43  2  78  162  29.72 
400
152  30  106  16 
N 7.1 9.1 0.9 insulin Y  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
57  Jayaraman  45  1  52  165  19.10 
23
253  51  160  42 
N 8.0 9.4 1.4 OHA N  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
58  Kanniyammal  53  2  64  139  33.10 
21
173  37  97  39 
N 8.0 7.9 2.8 Insulin Y  1.9 2.2 3.0 4.9 69 1.2 222 114 56 0.9 198
59  KUMAR  47  1  60  165  22.00 
400
176  36  90  50 
Y 9 8.9 1.0 OHA  N  0.6 0.7 2.4 4.5 67 0.9 209 100 41 0.4 160
60  Lalitha  48  2  70  165  25.71 
23
253  51  150  52 
N 9.5 10 0.6 OHA N  1.1 1.1 3.2 4.2 58 0.8 211 90 39 0.44 187
61  Lalitha  60  2  60  151  26.30 
21
177  36  92  49 
N 6.1
 
8.5 0.8 OHA N  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
62  Kousalya  41  2  67  169  23.46 
30
224  49  121  54 
N 9 9.1 0.9 insulin Y  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
63  Kamakshi  47  2  50  169  17.51 
1
198  40  136  22 
N 6.1
 
9.4 1.4 OHA Y  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
64  Ibrahim  46  1  65  166  23.60 
849
134  43.5  68  39 
N 9 7.0 1.1 OHa N  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189
65  gopi  47  1  62  153  26.49 
157
230  48  131  51 
Y 8.0 6.3 0.8 OHA Y  0.9 1.0 3.3 4.7 67 1.6 212 102 40 0.6 150
66  Ganesan  49  1  56  159  22.10 
190
171  36  112  23 
N 9 8.5 0.8 OHA Y  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
67  Eswaran  58  1  70  157  28.30 
456
132  28  70  34 
Y 9.5 9.1 0.9 insulin Y  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
68  Balaraman  54  1  82  174  27.10 
243
269  55  183  31 
N 7.2 9.4 1.4 OHA Y  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
69  Ramaiah  60  1  51  155  21.23 
221
108  25  58  25 
Y 7.9 2.8 1.1 Insulin N  1.9 2.2 3.0 4.9 69 1.2 222 114 56 0.9 198
70  Vijaykumar  60  1  67  152  29.00 
21
177  34  110  33 
Y 8.9 1.0 0.8 OHA  N  0.6 0.7 2.4 4.5 67 0.9 209 100 41 0.4 160
71  Vijayakumar  48  1  55  167  19.70 
23
106  22  53  31 
N 10 0.6 1.1 OHA N  1.1 1.1 3.2 4.2 58 0.8 211 90 39 0.44 187
72  Venkatachalapat  45  1  61  180  18.83 
234
185  37  124  24 
N 6.1
 
0.8 0.8 OHA Y  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189  
73  Varadan  49  1  68  160  26.00 
235
234  48  145  41 
N 9 8.5 0.8 OHA Y  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
74  Thiagaraj  60  1  50  153  21.40 
250
142  30  90  22 
Y 7.1 9.1 0.9 insulin N  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
75  Subramani  60  1  58  164  21.56 
600
180  36  123  21 
N 8.0 9.4 1.4 OHA Y  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
76  Sumathy  42  2  68  157  27.60 
25
163  33  116  14 
N 9 7.0 1.1 OHa N  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189
77  Ramu  57  1  50  145  23.78 
37
327  65  234  28 
N 9.5 6.3 0.8 OHA N  0.9 1.0 3.3 4.7 67 1.6 212 102 40 0.6 150
78  Raji  32  1  80  160  31.23 
368
271  46  196  29 
Y 6.1 7.0 1.1 OHa N  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189
79  Hussain  55  1  70  167  25.10 
900
240  48  119  73 
N 9 6.3 0.8 OHA Y  0.9 1.0 3.3 4.7 67 1.6 212 102 40 0.6 150
80  Nagaraj  38  1  83  171  28.42 
400
210  26  160  24 
N 6.3 8.5 0.8 OHA Y  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
81  James  52  1  65  167  23.30 
23
258  32  120  20 
Y 6.1
 
9.1 0.9 insulin N  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
82  Joseph  50  1  58  169  20.28 
21
270  37  203  30 
Y 9 9.4 1.4 OHA Y  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
83  Baskaran  67  1  72  174  23.70 
400
318  40  244  34 
Y 6.0 7.0 1.1 OHa Y  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189
84  Bagvathi  55  1  75  162  27.98 
23
158  30  102  26 
N 6.1
 
6.3 0.8 OHA Y  0.9 1.0 3.3 4.7 67 1.6 212 102 40 0.6 150
85  Devi Bai  45  2  60  172  23.47 
21
187  35  125  30 
N 9 7.0 1.1 OHa Y  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189
86  Duraisamy  37  1  72  164  26.00 
30
393  42  286  65 
N 8.0 6.3 0.8 OHA N  0.9 1.0 3.3 4.7 67 1.6 212 102 40 0.6 150
87 
Mohammed 
Ghouse  54  1  60  161  23.00 
1
210  50  126  34 
Y 9 8.5 0.8 OHA N  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
88  Pappammal  47  2  71  155  29.58 
849
178  32  122  24 
N 9.5 9.1 0.9 insulin N  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
89  Rajendran  50  1  76  167  27.21 
157
248  49  162  37 
N 6.1
 
9.4 1.4 OHA Y  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
90  Sheik Mohideen  52  1  58  165  21.32 
190
270  40  208  22 
N 9 7.0 1.1 OHa Y  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.60.41 189
91  Sugumaran  38  1  77  163  28.95 
456
215  50  140  25 
Y 6.2 6.3 0.8 OHA N  0.9 1.0 3.3 4.7 67 1.6 212 102 40 150
92  Vijaya  51  2  81  167  29.03 
243
214  46  140  28 
N 6.1
 
8.5 0.8 OHA Y  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
93  Velu  51  1  75  151  26.60 
221
272  48  191  33 
N 9 9.1 0.9 insulin N  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
94  Venkatesh  50  1  64  152  27.00 
21
217  41  150  26 
N 8.0 9.4 1.4 OHA N  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
95  Velu  33  1  70  168  24.82 
23
193  42  118  31 
Yy 9 7.0 1.1 OHa N  1.1 1.0 3.6 4.6 62 1.2 209 103 44 0.41 189
96  Ramu  65  1  60  166  21.76 
234
226  52  134  40 
Y 9.5 6.3 0.8 OHA Y  0.9 1.0 3.3 4.7 67 1.6 212 102 40 0.6 150
97  Sakunthala  38  2  56  146  26.29 
235
264  47  232  32 
Y 6.1
 
8.5 0.8 OHA Y  1.0 0.9 2.9 4.7 65 1.0 196 94 41 0.5 173
98  Pandiyan  37  1  62  149  27.93 
250
328  49  243  36 
N 9 9.1 0.9 insulin N  1.2 1.21 2.8 4.5 64 0.8 212 104 48 0.6 182
99  Paramisivam  45  1  75  175  24.50 
600
189  48  106  37 
N 6.1
 
9.4 1.4 OHA Y  1.3 1.3 2.6 4.4 62 0.7 215 105 52 0.7 180
100  Rajendran  31  1  56  168  19.86 
25
186  42  116  28 
Y 9 7.9 2.8 Insulin Y  1.9 2.2 3.0 4.9 69 1.2 222 114 56 0.9 198
101  Rajendran  58  1  68  162  25.95 
37
278  40  210  28 
N 9.5 8.9 1.0 OHA  Y  0.6 0.7 2.4 4.5 67 0.9 209 100 41 0.4 160
102  Mohammed  36  1  75  175  24.50 
368
189  48  106  37 
N 8.1 10 0.6 OHA Y  1.1 1.1 3.2 4.2 58 0.8 211 90 39 0.44 187
 
